← Retour au Screener

Sector: Santé
Open in Terminal → REG1V.HELive chart · Key metrics · News · Smart money

Revenio Group

REG1V.HE Small Cap

Healthcare · Medical Devices

Mis à jour: Aug 2, 2026, 22:14 UTC

12,22 €
-0.81% aujourd'hui
52W: 11,86 € – 26,35 €
52W Low: 11,86 € Position: 2.5% 52W High: 26,35 €

Price Chart

Indicateurs clés

P/E Ratio
20.71x
Cours/Bénéfice
Forward P/E
12.58x
P/E prévisionnel
P/S Ratio
3.2x
Cours/Ventes
EV/EBITDA
13.39x
Valeur d'entreprise/EBITDA
Rend. dividende
3.27%
Rendement annuel du dividende
Cap. boursière
308 M €
Capitalisation boursière
Croissance du CA
4.6%
Croissance du CA sur un an
Marge bénéficiaire
14.15%
Marge nette
ROE
13.7%
Rentabilité des capitaux propres
Beta
0.85
Sensibilité au marché
Positions vendeuses
% du flottant vendu à découvert
Volume moyen
46,611
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
4 analysts
Avg. Price Target
19,38 €
+58.55% upside
Target Range
15,00 € – 23,50 €

About the Company

Sector: Healthcare Industry: Medical Devices Country: Finland Employees: 246 Exchange: HEL

Revenio Group en bref

Revenio Group (REG1V.HE) is currently trading at 12,22 € with a market capitalization of 308 M €. The trailing P/E ratio stands at 20.71x, with a forward P/E of 12.58x. The 52-week range spans from 11,86 € to 26,35 €; the current price is 53.6% below the yearly high. Year-over-year revenue growth stands at +4.6%. The net profit margin stands at 14.15%.

💰 Dividende

Revenio Group pays an annual dividend of 0,40 € per share, representing a yield of 3.27%. The payout ratio stands at 67.85%.

📊 Avis des analystes

4 analystes évaluent Revenio Group (REG1V.HE) au consensus : None. L'objectif de cours moyen est de 19,38 €, soit un potentiel de +58.55% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 15,00 € à 23,50 €.

Revenio Group : la thèse d'investissement en détail

Revenio Group (REG1V.HE) operates in the Healthcare — specifically Medical Devices — and is headquartered in Finland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 69.94%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

Le scénario baissier

Revenue growth has slowed to just 4.6%, which is below nominal GDP — the business is no longer outgrowing the broader economy.

Valorisation en contexte

At a PEG of 6.37, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.

À surveiller

  • The forward P/E of 12.58x is meaningfully below the trailing 20.71x — analysts expect earnings to step up; the next earnings release is the test.
  • The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
  • The dividend yield near 3.27% combined with a payout ratio of 67.85% leaves room for further hikes — a track record of consecutive raises is a strong income signal.
  • The analyst consensus price target implies 58.55% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Marge brute élevée de 69.94% — signe d'un pouvoir de fixation des prix
  • Rendement du dividende solide de 3.27%
  • Bilan solide avec faible endettement (D/E 9.21)
  • Free cash flow positif
Points faibles

Aucun signal d'alerte significatif dans les indicateurs actuels.

Aperçu technique

MM 50 jours
12,74 €
-4.08% vs. cours
MM 200 jours
18,14 €
-32.64% vs. cours
Sous le plus haut 52s
−53.6%
26,35 €
Au-dessus du plus bas 52s
+3%
11,86 €

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

Risque de marché (Bêta)
0.85 · Proche du marché
Évolue moins que le marché global
Dette/Capitaux propres
9.21 · Faible
Dette totale / capitaux propres

The data points to relatively defensive market behavior.

Trading Data

50-Day MA: 12,74 €
200-Day MA: 18,14 €
Volume: 72,756
Avg. Volume: 46,611
Short Ratio:
P/B Ratio: 2.83x
Debt/Equity: 9.21x
Free Cash Flow: 12 M €

💵 Dividend Info

Dividend Yield
3.27%
Annual Rate
0,40 €
Payout Ratio
67.85%

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Revenio Group?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut